PMS-PROGESTERONE CAPSULE
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
15-08-2018
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
PROGESTERONE
Inapatikana kutoka:
PHARMASCIENCE INC
ATC kanuni:
G03DA04
INN (Jina la Kimataifa):
PROGESTERONE
Kipimo:
200MG
Dawa fomu:
CAPSULE
Tungo:
PROGESTERONE 200MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
30/100
Dawa ya aina:
Prescription
Eneo la matibabu:
PROGESTINS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0106327003; AHFS:
Idhini hali ya:
APPROVED
Idhini ya tarehe:
2018-08-22
Tabia za bidhaa
PRODUCT MONOGRAPH
Pr
PMS-PROGESTERONE
Progesterone Capsules
200 mg
PROGESTIN
PHARMASCIENCE INC.
DATE OF PREPARATION:
6111 Ave. Royalmount
August 20, 2018
Montréal, Québec
H4P 2T4
www.pharmascience.com
Submission Control No: 211548
_pms-PROGESTERONE Product Monograph Page 2 of 33_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
........................................................................
3
INDICATIONS AND CLINICAL USE
..............................................................................
3
CONTRAINDICATIONS
...................................................................................................
3
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
.................................................................................................
10
DRUG INTERACTIONS
..................................................................................................
14
DOSAGE AND ADMINISTRATION
..............................................................................
15
OVERDOSAGE
................................................................................................................
16
ACTION AND CLINICAL PHARMACOLOGY
............................................................ 16
STORAGE AND STABILITY
.........................................................................................
18
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................. 18
PART II: SCIENTIFIC INFORMATION
...............................................................................
19
PHARMACEUTICAL INFORMATION
.........................................................................
19
CLINICAL TRIALS
..........................................................................................................
20
TOXICOLOGY
...........................................................................
Soma hati kamili
